123350-49-2

Upstream product

• 123350-52-7 2(S)-<(tert-butyloxycarbonyl)amino>-3-cyclohexyl-1(S)-hydroxy-1-(1-methyl-2-oxopiperidin-3(S)-yl)propane 
• 129941-29-3 2(S)-<(tert-butyloxycarbonyl)amino>-3-cyclohexyl-1(S)-hydroxy-1-(1-methyl-2-oxopiperidin-3(R)-yl)propane 
• 98105-42-1 (S)-2-(t-butoxycarbonylamino)-3-cyclohexyl-1-propanal 
• 931-20-4 1-methylpiperidin-2-one 

Downstream Products

• 123362-96-9 {(S)-1-[(1S,2S)-1-Cyclohexylmethyl-2-hydroxy-2-((R)-1-methyl-2-oxo-piperidin-3-yl)-ethylcarbamoyl]-2-[1-(2,4-dinitro-phenyl)-1H-imidazol-4-yl]-ethyl}-carbamic acid tert-butyl ester 
• 123362-96-9 {(S)-1-[(1S,2S)-1-Cyclohexylmethyl-2-hydroxy-2-((S)-1-methyl-2-oxo-piperidin-3-yl)-ethylcarbamoyl]-2-[1-(2,4-dinitro-phenyl)-1H-imidazol-4-yl]-ethyl}-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

Renin Inhibitors Containing Conformationally Restricted P1-P1' Dipeptide Mimetics

A series of renin inhibitors containing lactam-bridged P1-P1' dipeptide mimetics based on the ACHPA (4(S)-amino-5-cyclohexyl-3(S)-hydroxypentanoic acid) design was studied.The inhibitors were obtained by aldol addition of various lac